Guillain-Barré Syndrome: Immunotherapy
Skip to the navigation
Guillain-Barré syndrome is a rare nerve disorder that occurs when the body's own defenses (immune system) attack part of the nervous system. For this reason, you may be treated with immunotherapy, which is designed to alter or combat the abnormal immune response by removing the antibodies that are attacking your body.
Two types of immunotherapy may be used to treat Guillain-Barré syndrome:
One of these treatments is often started immediately after you have been diagnosed if you seem to be getting worse. Early treatment may reduce your recovery time.
Plasma exchange and IVIG appear to be equally effective when given early in the course of the disease. They also have similar costs. The choice between one or the other treatment may depend on what is available and most practical.
Primary Medical Reviewer Anne C. Poinier, MD - Internal Medicine
Specialist Medical Reviewer Colin Chalk, MD, CM, FRCPC - Neurology
Current as ofOctober 9, 2017
To learn more about Healthwise, visit Healthwise.org .
© 1995-2018 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.